Pre-Approval Access to Rilpivirine Long Acting (RPV LA) Injectable Suspension for the Treatment of a Participant With Human Immunodeficiency Virus (HIV)-1 Infection
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Janssen Sciences Ireland UC
With
ViiV Healthcare
Age
Any age
Sex
Any
Healthy volunteers
Not accepted
Clareo Health | Pre-Approval Access to Rilpivirine Long Acting (RPV LA) Injectable Suspension for the Treatment of a Participant With Human Immunodeficiency Virus (HIV)-1 Infection
